Author:
Muhammad Ammar,van der Lely Aart J,Delhanty Patric J D,Dallenga Alof H G,Haitsma Iain K,Janssen Joseph A M J L,Neggers Sebastian J C M M
Subject
Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism
Reference33 articles.
1. Medical progress: acromegaly;Melmed;N Engl J Med,2006
2. A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly;Holdaway;Eur J Endocrinol,2008
3. A comprehensive study of clinical, biochemical, radiological, vascular, cardiac, and sleep parameters in an unselected cohort of patients with acromegaly undergoing presurgical somatostatin receptor ligand therapy;Annamalai;J Clin Endocrinol Metab,2013
4. Acromegaly clinical trial methodology impact on reported biochemical efficacy rates of somatostatin receptor ligand treatments: a meta-analysis;Carmichael;J Clin Endocrinol Metab,2014
5. Tumor shrinkage with lanreotide autogel 120 mg as primary therapy in acromegaly: results of a prospective multicenter clinical trial;Caron;J Clin Endocrinol Metab,2014
Cited by
63 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献